Century Therapeutics (IPSC) EPS (Basic) (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly EPS (Basic) of -$0.47 for Q1 2026, down 152.8% year-over-year from $0.89 in Q1 2025, and down 326.02% quarter-over-quarter from -$0.11 in Q4 2025.
Powered by 
Analysis
Century Therapeutics (IPSC) EPS (Basic) (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported EPS (Basic) for 7 consecutive years, with -$0.47 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 152.8% year-over-year to -$0.47; the TTM figure through Mar 2026 stood at -$0.87 (down 245.48% YoY), while the FY2025 annual figure was $0.02, up 101.49% from the prior year.
- EPS (Basic) fell to -$0.47 in Q1 2026 per IPSC's latest filing, from -$0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.89 in Q1 2025 and bottomed at -$0.66 in Q4 2023.
- Historically, EPS (Basic) has averaged -$0.39 across 5 years, with a median of -$0.47 in 2026.
- Annual changes were most pronounced in 2025 — EPS (Basic) surged 297.58% — and 2026, when it slumped 152.8%.
- Century Therapeutics' EPS (Basic) stood at -$0.55 in 2022, then slipped by 21.09% to -$0.66 in 2023, then surged by 31.71% to -$0.45 in 2024, then jumped by 75.68% to -$0.11 in 2025, then slumped by 326.02% to -$0.47 in 2026.
- Business Quant data shows IPSC's EPS (Basic) at -$0.47 in Q1 2026, -$0.11 in Q4 2025, and -$0.4 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - | -0.17 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.17 |
| Mar 31, 2026 | -0.11 |
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | 0.89 |
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.38 |
| Mar 31, 2024 | -0.45 |
| Dec 31, 2023 | -0.66 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.56 |
| Mar 31, 2023 | -0.53 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.53 |
| Jun 30, 2022 | -0.54 |
| Mar 31, 2022 | -0.66 |
| Dec 31, 2021 | -0.87 |
| Sep 30, 2021 | -0.48 |